Manuel J. Ramos-Moreno
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Therapeutic management of axial spondyloarthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA).
Journal: Therapeutic advances in musculoskeletal disease
Published: January 18, 2026
Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.
Journal: Seminars in arthritis and rheumatism
Published: October 12, 2025
Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 study.
Journal: RMD open
Published: June 16, 2025
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry.
Journal: Arthritis research & therapy
Published: October 14, 2024
How Are We Addressing Axial Psoriatic Arthritis in Clinical Practice?
Journal: Rheumatology and therapy
Published: July 24, 2024
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.
Journal: Annals of the rheumatic diseases
Published: November 13, 2023
Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert's Document Based on a Systematic Literature Review and Extended Delphi Process.
Journal: Rheumatology and therapy
Published: May 22, 2023
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.
Journal: European journal of clinical investigation
Published: May 09, 2023
Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis.
Journal: Frontiers in medicine
Published: October 24, 2022
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Journal: Rheumatology and therapy
Published: September 05, 2022
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Journal: Rheumatology and therapy
Published: February 09, 2022
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.
Journal: Scientific reports
Published: March 25, 2021
Last Updated: 09/26/2026